APRE
Aprea TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
APRE Profile
Aprea Therapeutics, Inc.
A biopharmaceutical company focused on developing and commercializing novel cancer therapeutics targeting DNA damage response pathways
3805 Old Easton Road, Doylestown, Pennsylvania 18902
--
Aprea Therapeutics, Inc., was incorporated under the laws of the State of Delaware in May 2019. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing novel cancer therapies that reactivate mutant p53 tumor suppressor proteins.
